Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.14M Buy
158,089
+35,033
+28% +$2.01M 0.01% 566
2026
Q1
$6.83M Buy
123,056
+3,644
+3% +$236K 0.01% 576
2025
Q4
$7.47M Buy
119,412
+6,458
+6% +$384K 0.01% 573
2025
Q3
$6.52M Buy
112,954
+10,900
+11% +$584K 0.01% 577
2025
Q2
$5.03M Buy
102,054
+9,760
+11% +$448K 0.01% 590
2025
Q1
$4.08M Buy
92,294
+13,562
+17% +$674K 0.01% 549
2024
Q4
$3.7M Buy
+78,732
New +$3.79M 0.01% 567
2024
Q3
Sell
-116,358
Closed -$4.41M 911
2024
Q2
$4.41M Buy
+116,358
New +$4.21M 0.01% 517
2023
Q3
Sell
-33,023
Closed -$1.07M 990
2023
Q2
$1.07M Sell
33,023
-66,728
-67% -$2.05M ﹤0.01% 808
2023
Q1
$3.31M Buy
99,751
+16,749
+20% +$516K 0.02% 613
2022
Q4
$2.27M Buy
+83,002
New +$2.41M 0.01% 694
2021
Q4
Sell
-27,451
Closed -$999K 1028
2021
Q3
$999K Buy
27,451
+21,415
+355% +$787K ﹤0.01% 936
2021
Q2
$223K Buy
+6,036
New +$211K ﹤0.01% 856
2019
Q2
Sell
-80,750
Closed -$2.9M 801
2019
Q1
$2.9M Sell
80,750
-5,857
-7% -$200K 0.02% 590
2018
Q4
$2.63M Buy
+86,607
New +$2.67M 0.02% 589
2014
Q2
Sell
-43,818
Closed -$1.1M 828
2014
Q1
$1.1M Hold
43,818
0.01% 764
2013
Q4
$1.16M Hold
43,818
0.01% 752
2013
Q3
$1.02M Hold
43,818
0.01% 778
2013
Q2
$893K Buy
+43,818
New +$887K 0.01% 777

Other funds holding GIL

Aviva's GIL Position: Q2 2026 in Review

Aviva increased its Gildan (GIL) stake by 28% in Q2 2026, buying an estimated $2.01M and bringing the position to 158,089 shares worth $8.14M. The position accounts for 0.01% of the portfolio, ranked #566.

Aviva first reported a position in GIL in Q2 2013 and has held it in 19 quarters since. 463 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

  • Aviva held 158,089 shares of Gildan worth $8.14M as of Q2 2026.
  • Aviva bought 35,033 Gildan shares in Q2 2026, an estimated $2.01M.
  • Gildan made up 0.01% of Aviva's portfolio in Q2 2026, its #566 holding.
  • Aviva first reported a position in Gildan in Q2 2013 and has held it in 19 quarters since.
  • 463 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.